Tag: Drugs of abuse

Analytical Strategies for USP Residual Solvents Analysis

In this presentation, we will present the relevant GC/FID and GC/FID/MS based analytical strategies to confidently detect and quantify Class 1, 2, and 3 as well as unknown solvents in drug products. Learn how taking advantage of dual channel configuration and Agilent’s Smart, Connected, and Self-Aware systems can help you successfully meet your requirements for residual solvent analysis and ensure your testing is right first time and every time.

 

What will you learn

  • Understand what residual solvent impurities are and why it’s important to characterise and quantify them, even when present in trace amounts
  • Understand the current regulatory guidelines for residual solvent analysis in drug substance and product
  • Learn about the approaches for the confident identification and quantification of residual solvents

 

Who should attend this webinar

  • Laboratory managers
  • Chromatographers
  • Analytical chemists and scientists
  • New product developers
  • Pharma quality control managers

 

Speaker

Ian Eisele
Applications Chemist,
Gas Phase Separation Division,
Agilent Technologies

 

Youjuan Zhang
Applications Chemist,
Gas Phase Separation Division,
Agilent Technologies

 

Register and watch on demand >

 

Forensics Series Part 3: Using UV-Vis as a Rapid Screen for the Purity of a Drug of Abuse – Methamphetamine

In the world of Forensic Analysis, purity is an important calculation.  Using UV-Vis as a rapid screening technique for methamphetamine allows labs to optimize their time which is critical due to increase caseloads. The Cary 60 and 18-cell changer or fiber optic probe is ideal for this application. This presentation will look at the mechanics behind using the Cary 60 to determine the purity of a methamphetamine sample.

 

Speakers

Mark Fisher, PhD, Application Engineer, Molecular Spectroscopy, Agilent Technologies, Inc.

Mark, an Application Scientist for Agilent Technologies, has over 30 years of experience in molecular spectroscopy. He has held roles in Agilent’s UV-Vis-NIR, fluorescence, and atomic absorption product portfolios. In addition to identifying industry trends and new business needs, Mark’s responsibilities include application development, pre and post-sales support, as well as acting as a customer advocate for new product and technology opportunities. Mark received his doctorate in analytical chemistry from the University of Nebraska-Lincoln.

 

Register Here >